We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Japan's Ono Pharmaceuticals recently reported that GlaxoSmithKline began Phase III trials in June of an experimental anti-AIDS pill, which was licensed from Ono.
BioAlliance Pharma, a biopharmaceutical company focused on the field of drug resistance, announced today that it has submitted an Investigational New Drug Application (IND) to the FDA to conduct a pivotal Phase III clinical trial of its antifungal agent, miconazole Lauriad.
Shire Pharmaceuticals announced that the FDA has approved Adderall XR as a once-daily treatment for adolescents aged 13 to 17 with attention-deficit/hyperactivity disorder (ADHD).
Incyte announced positive results from Study 203, a six-month randomized double-blind Phase IIb trial, involving 199 patients and 25 clinical sites in the U.S. and Europe to evaluate the efficacy, dose response, safety and tolerability of Reverset in treatment-experienced human immunodeficiency virus (HIV) infected patients who are failing their current treatment regimens.
Aradigm and APT Pharmaceuticals announced the program advancement of APT's proprietary formulation of hydroxychloroquine into Phase II clinical trials.
Myogen, has announced the completion of enrollment of 187 patients in ARIES-2, one of the company's two pivotal Phase III trials of ambrisentan in patients with pulmonary arterial hypertension (PAH).
Advancis Pharmaceutical announced that the company's Amoxicillin Pulsys Phase III clinical trial for the treatment of children with pharyngitis/tonsillitis due to Group A streptococcal infections (commonly referred to as strep throat) failed to achieve its desired microbiological and clinical endpoints.
Newron Pharmaceuticals has announced the completion of patient enrollment in its Phase III trial with Safinamide for the treatment of Parkinson's disease.
Eli Lilly and Alkermes initiated a Phase III clinical trial required for registration for their inhaled insulin system, which is being investigated as an innovative treatment option for diabetes.